The world’s newest petrostate heads to the polls
FT News Briefing
00:00
AstraZeneca's Strategic Investment and Challenges in China
This chapter examines AstraZeneca's $2.5 billion investment in a new research center in Beijing, highlighting its strategic partnership with the Chinese government amid recent controversies. It also discusses the implications of this move for AstraZeneca's market position and the challenges posed by the current work environment.
Transcript
Play full episode
